V. Compan et al., LESION STUDY OF THE DISTRIBUTION OF SEROTONIN 5-HT4 RECEPTORS IN RAT BASAL GANGLIA AND HIPPOCAMPUS, European journal of neuroscience, 8(12), 1996, pp. 2591-2598
The regional distribution of 5-hydroxytryptamine (5-HT4) receptors lab
elled with [H-3]GR113808 was examined in rat basal ganglia and hippoca
mpus after specific lesions. Lesion of serotonin neurons induced by in
jections of 5,7-dihydroxytryptamine into the dorsal and medial raphe n
uclei resulted in increased 5-HT4 receptor binding in most regions exa
mined, compared with controls. More precisely, there was a 78% increas
e in the rostral but no change in the caudal part of caudate-putamen,
and 83% and 54% increases in the shell and core of the nucleus accumbe
ns respectively. In the substantia nigra, the increase in 5-HT4 bindin
g was larger (72%) than that in the globus pallidus (32%). In the hipp
ocampus, 63%, 30% and 28% increases were measured in CA2, CA1 and CA3
respectively. Following lesion of dopamine neurons by intranigral inje
ction of 6-hydroxydopamine, increased 5-HT4 receptor binding was obser
ved in the caudal (59%), but not the rostral part or caudate-putamen,
as well as in the globus pallidus (93%). Since no decreases in 5-HT4 r
eceptor density were detected after the dopamine lesion, it was conclu
ded that these receptors are not expressed in dopamine neurons. Kainic
acid lesions of the caudate-putamen were associated with dramatic loc
al decreases in 5-HT4, receptor binding on the injected side (-89%), w
hich suggested that striatal neurons express 5-HT4 receptors. Correspo
nding decreases of 72 and 20% in receptor density were detected in glo
bus pallidus and substantia nigra, consistent with a presumed localiza
tion of 5-HT4 receptors on striatal GABA neurons projecting to these r
egions. in the substantia nigra, the decrease in [H-3]GR113808 binding
was localized to the pars lateralis, indicating that striatal neurons
belonging to the cortico-striato-nigro-tectal pathway, and containing
GABA and dynorphin, express 5-HT4 receptors.